Evidence map›Paper›PMID 40670671›Full record

ArticleLeukemia2025

Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis.

Kritika Yadav, Meera Mohan, Charlotte Wagner, Rajshekhar Chakraborty, Douglas Sborov, Amandeep Godara, Brian McClune, Carolina Schinke, Binod Dhakal, Anita D'Souza and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kritika YadavDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Meera MohanDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-6913-6526
Charlotte WagnerDivision of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.ORCID http://orcid.org/0000-0003-0568-0781
Rajshekhar ChakrabortyMultiple Myeloma and Amyloidosis Program, Columbia University, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
Douglas SborovDivision of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.
Amandeep GodaraDivision of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.
Brian McCluneDivision of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.
Carolina SchinkeMyeloma Center, University of Arkansas for Medical Science, Little Rock, AR, USA.ORCID http://orcid.org/0000-0002-2699-1741
Binod DhakalDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-4377-9742
Anita D'SouzaDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-1092-5643
Aniko SzaboDivision of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-8129-0614
Ghulam Rehman MohyuddinDivision of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA. g.mohyuddin@hci.utah.edu.ORCID http://orcid.org/0000-0001-6464-783X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40670671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.